Choosing which genes to screen in newborns for health benefits
Gene Selection for Newborn Sequencing Studies
['FUNDING_R21'] · RESEARCH TRIANGLE INSTITUTE · NIH-10871075
This study is looking at how to choose the right genes to test for in newborn screening programs, with the aim of making sure that these tests are helpful and trustworthy for families, so that more babies can get the lifesaving care they need.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RESEARCH TRIANGLE INSTITUTE (nih funded) |
| Locations | 1 site (RESEARCH TRIANGLE PARK, UNITED STATES) |
| Trial ID | NIH-10871075 on ClinicalTrials.gov |
What this research studies
This research investigates how public health programs can decide which genes to include in newborn screening tests. By analyzing existing studies and gathering input from experts and community members, the project aims to identify the best criteria for gene selection. The goal is to ensure that newborn screening is effective and trusted, ultimately increasing access to lifesaving interventions for infants. The research will also address the ethical, legal, and social implications of newborn sequencing.
Who could benefit from this research
Good fit: Ideal candidates for this research are newborns and their families who may benefit from enhanced screening for genetic diseases.
Not a fit: Patients who are older than newborns or those who do not have access to newborn screening programs may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved newborn screening programs that save lives by identifying genetic conditions early.
How similar studies have performed: Other research has shown success in improving newborn screening processes, making this approach both relevant and timely.
Where this research is happening
RESEARCH TRIANGLE PARK, UNITED STATES
- RESEARCH TRIANGLE INSTITUTE — RESEARCH TRIANGLE PARK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PEAY, HOLLY LANDRUM — RESEARCH TRIANGLE INSTITUTE
- Study coordinator: PEAY, HOLLY LANDRUM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.